Nasal stem cell spray shows promise for stroke patients in early trial
NCT ID NCT07232563
First seen Nov 18, 2025 · Last updated May 22, 2026 · Updated 22 times
Summary
This early study tests the safety of a nasal spray made from tiny particles (extracellular vesicles) derived from umbilical cord stem cells in 9 people who had an ischemic stroke. The goal is to see if it is safe and if it might help the brain heal. Participants must be between 18 and 70 years old and within 24 hours to 14 days of their stroke.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
253 Gongye Blvd Middle, Guangzhou, Guangdong, China 510280
Guangzhou, Guangdong, 510000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.